跳至主要内容
临床试验/NCT01919411
NCT01919411已完成4 期

Prophylactic Antibiotics After Functional Endoscopic Sinus Surgery: a Randomized, Double-blind Placebo Controlled Trial

Massachusetts Eye and Ear Infirmary1 个研究点 分布在 1 个国家目标入组 134 人开始时间: 2013年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
134
试验地点
1
主要终点
Sinonasal Outcome Test - 22

研究概览

简要总结

Surgeons commonly prescribe post operative prophylactic antibiotics after sinus surgery. There is minimal data to support this. The investigators' study will aim to demonstrate that patients' quality of life and rate of post operative infection is the same whether they receive or do not receive antibiotics post operatively. The investigators hypothesis is that the disease specific quality of life of patients taking post-operative antibiotics is not inferior to the quality of life of patients who do not take post-operative antibiotics, and the rate of post-operative infections are the same. The investigators' specific aim is to compare validated symptom scores between post-operative populations who are given or are not given antibiotics. Rates of infections in the first 10 days after surgery will be recorded. The investigators will also compare endoscopic grades of sinus cavities during the post-operative follow up exams as an additional outcome measure.

详细描述

Functional endoscopic sinus surgery (FESS) is a commonly performed procedure in the United States to treat chronic rhinosinusitis. Common practice is to prescribe prophylactic antibiotics postoperatively. This is similar to the long tradition of prophylactic antibiotics after tonsillectomy. The American Academy of Otolaryngology - Head and Neck Surgery recently strongly recommended against prophylactic antibiotics after tonsillectomy. In this light, this study would demonstrate the lack of need for antibiotics after FESS. Currently one surgeon does not prescribe antibiotics except when evidence of active infection was found during surgery. The other surgeon in the study currently prescribes antibiotics. This study would prospectively compare the two groups in a randomized fashion. The investigators' plan to use the Sinonasal outcomes test - 22 (SNOT-22) as the investigators' primary outcomes measure, which is a validated quality of life instrument in sinusitis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients eligible for surgery would be patients with chronic rhinosinusitis (defined by the AAOHNS 2007 consensus statement by Rosenfeld et al) and have been determined by their surgeons to have persistent symptoms after maximal medical therapy. Maximal medical therapy is defined as a course of broad spectrum or culture-directed antibiotics used in conjunction with a nasal steroid.

排除标准

  • Penicillin, cephalosporin, amoxicillin/clavulanate allergy
  • Cystic Fibrosis
  • Immunodeficiency
  • Presence of any foreign body (ie.absorbable and non-absorbable packing) after surgery
  • Odontogenic causes of sinusitis
  • Fungal ball
  • Infected mucocele
  • Complication of sinusitis (meningitis, orbital complication, cellulitis, brain abscess)
  • Non endoscopic sinus surgery (Caldwell luc, external approaches, etc)
  • Pregnant women

研究组 & 干预措施

Amoxicillin-Potassium Clavulanate

Experimental

All patients in the study will undergo endoscopic sinus surgery. This arm will receive 7 days of augmentin (amoxicillin-clavulanate) 500mg orally twice a day after surgery.

干预措施: Amoxicillin-Potassium Clavulanate (Drug)

Placebo

Placebo Comparator

All patients in the study will undergo endoscopic sinus surgery. This arm will receive 7 days of placebo orally twice a day after surgery.

干预措施: Placebo (Drug)

结局指标

主要结局

Sinonasal Outcome Test - 22

时间窗: Six weeks post operatively

The sinonasal outcome test -22 (SNOT-22) is a validated instrument for measuring quality of life outcomes in chronic sinusitis. Snot-22 scores can range from 0 to 110. Higher scores indicate more severe symptoms.

次要结局

  • Lund Kennedy Endoscopic Score(Six weeks postoperatively)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Eric Holbrook

Principal Investigator

Massachusetts Eye and Ear Infirmary

研究点 (1)

Loading locations...

相似试验